Loss of Hep Par 1 immunoreactivity in the livers of patients with carbamoyl phosphate synthetase 1 deficiency-Reference-Cited by-同舟云学术

Loss of Hep Par 1 immunoreactivity in the livers of patients with carbamoyl phosphate synthetase 1 deficiency

Published:2016-05-05 Issue:6 Volume:66 Page:333-336
ISSN:1320-5463
Container-title:Pathology International
language:en
Short-container-title:Pathology International

Author:

Yamaguchi Maki¹,Kataoka Tatsuki R.²,Shibayama Takahiro¹,Fukuda Akinari³,Nakazawa Atsuko⁴,Minamiguchi Sachiko¹,Sakurai Takaki¹,Miyagawa‐Hayashino Aya¹,Yorifuji Toru⁵,Kasahara Mureo³,Uemoto Shinji²,Haga Hironori¹

Affiliation:

1. Department of Diagnostic Pathology Kyoto University Hospital Kyoto Japan

2. Organ Transplant Unit Kyoto University Hospital Kyoto Japan

3. Organ Transplantation Center National Center for Child Health and Development Tokyo Japan

4. Division of Clinical Pathology National Center for Child Health and Development Tokyo Japan

5. Department of Pediatrics Osaka City General Hospital Osaka Japan

Funder

FUSO Pharmaceutical Industries, LTD.

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Wiley

Subject

General Medicine,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pin.12414

Reference9 articles.

1. Hepatocyte paraffin 1: A monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors;Wennerberg AE;Am J Pathol,1993

2. Expression of Hepatocyte Antigen in Small Intestinal Epithelium and Adenocarcinoma

3. The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1

4. Genetic variation in the urea cycle: a model resource for investigating key candidate genes for common diseases

5. Molecular defects in human carbamoy phosphate synthetase I: mutational spectrum, diagnostic and protein structure considerations